Nihal Essa Abdulla MD
Hematologic Oncology
Faculty member- Assistant Professor
Join to View Full Profile
3822 Katella AveLos Alamitos, CA 90720
Phone+1 562-735-0602
Fax+1 562-490-8590
Dr. Abdulla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Nihal Abdulla, MD, is a hematologist oncologist based in Los Alamitos, CA, specializing in hematology oncology. He completed his residency in internal medicine and fellowship in medical oncology at the University of Texas Medical Branch Hospitals. He is experienced with conditions such as amyloidosis, myelodysplasia, myelofibrosis, and multiple myeloma. Expertise in breast, prostate, lung, GI cancers where he has been principal investigator for multiple clinical trials. Dr. Abdulla has contributed to various publications, including a notable study on INK4A promoter methylation, which has been widely cited. He has been involved in multiple clinical trials addressing advanced solid tumors and specific lung and breast cancers. He has received CMS Meaningful Use Stage certifications and was recognized as Most Compassionate Doctor by the American Registry.
Education & Training
University of Texas Medical Branch HospitalsFellowship, Medical Oncology, 2006 - 2008- University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2003 - 2006
Dow University of Health SciencesClass of 2000
Certifications & Licensure
TX State Medical License 2008 - 2028
CA State Medical License 2012 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification CureMD SMART Cloud, CureMD.com, Inc., 2014-2015, 2018
- CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2014-2015, 2018
- Most Compassionate Doctor American Registry
Clinical Trials
- Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer Start of enrollment: 2023 Jan 24
- Study of LP-184 in Patients With Advanced Solid Tumors Start of enrollment: 2023 Jun 09
- Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors Start of enrollment: 2023 Jan 03
Publications & Presentations
PubMed
- 1 citationsPhase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatm...J Nicholas Bodor, Jonathan Dowell, Joseph Treat, Janakiraman Subramanian, Nihal Abdulla
Clinical Lung Cancer. 2025-09-01 - Intravenous Steroids for Refractory Chemotherapy-Related Diarrhea: A Case Report.Kishan Patel, Adrian Dang, Mai M Makhlouf, Alex G Raman, Nihal E Abdulla
Cureus. 2023-02-01 - 45 citationsEvaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinomaGengming Huang, Joseph D. Krocker, Jason L. Kirk, Shehzad Merwat, Hyunsu Ju
Clinical Chemistry and Laboratory Medicine. 2014-06-01
Professional Memberships
- Member
- Member
Other Languages
- Spanish, Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
